• Welcome
  • The Board
  • Our Investors
  • soloMER Technology
  • Licensing Opportunities
  • Pipeline
  • Publications
  • Contact
  • News
ELASMOGEN

Elasmogen to present new data at the Nextgen Biomed Conference, 12-14th March 2025

by Lorna Bowers | Mar 5, 2025 | News

Dr Obinna C Ubah ((Principal Scientist and Future Leaders Fellow(UKRI)) and Dr Euan Murray (Senior Scientist) will be presenting the latest data on our first-in-class soloMER drug conjugate, ELN28. Obinna’s talk, “First-in-class Site-directed targeted...
Elasmogen Presenting at World ADC Conference in London (3rd to 5th March 2025)

Elasmogen Presenting at World ADC Conference in London (3rd to 5th March 2025)

by Lorna Bowers | Mar 5, 2025 | News

DR OBINNA C UBAH (Principal Scientist and Future Leaders Fellow (UKRI)) who leads our autoimmune inflammatory disease team is presenting new data on our lead first in class drug conjugate, ELN 28. His poster entitled, “Development and functional characterisation...

News archives

  • May 2025
  • March 2025
  • December 2024
  • June 2024
  • April 2024
  • November 2023
  • June 2023
  • May 2023
  • April 2023
  • December 2022
  • September 2022
  • May 2022
  • December 2021
  • September 2021
  • January 2021
  • December 2020
  • July 2020
  • May 2020
  • April 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • July 2019
  • May 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • August 2018
  • May 2018
  • January 2018
  • November 2017
  • May 2017
  • March 2017
  • January 2017
  • August 2016
  • July 2016
  • March 2016
  • December 2015
  • Follow
welcome
the board
our investors
soloMER® technology
licensing opportunities
pipeline
publications
contact
news

Liberty Building
Foresterhill Health Campus
Foresterhill Rd
Aberdeen AB25 2ZP

t: (+44) 070 7721 0755